TSA-II – NeuroSensory Analyzer

NeuroSensory Analyzer

An essential Quantitative Sensory Testing (QST) tool for evaluating nerve impairment and sensory testing in clinical, research and pharmacological trial settings

What is TSA-II? 

TSA-II – NeuroSensory Analyzer is a precise, computer-controlled device capable of generating and documenting response to highly repeatable thermal and vibratory stimuli, such as warmth, cold, heat-induced pain, cold-induced pain or vibration.

TSA-II NeuroSensory Analyzer System

What would the results show? 

A deviation from the normal range can indicate the existence of peripheral nerve disease or damage due to injury, illness or toxic exposure. Testing comparing contra-lateral body sites and longitudinal (or serial) evaluation before and after therapy can also be routinely employed.

Can I get the test report? 

Test result reports are generated in a variety of graphical formats.

Dr. Martin Angst  from the department of anesthesia at Stanford University is using the TSA II for determining heat and mechanical pain threshold as described here.

TSA-II Features

  • Outcome-based color graphic reports with automated narrative discussion of test results for insurance and referral networks
  • Automatic comparison of test results to normative reference data
  • Portable, fast set-up and ease of use
  • Versatile WINDOWST based software with selection of test paradigms for maximum flexibility in clinical, research and drug trial applications.
  • Various test methods (Limits, Levels and Manual)
  • Factory installed default protocols for immediate clinical use
  • Proven Repeatability

Useful in monitoring, treating and testing in:

  • Fibromyalgia
  • Painful neuropathies
  • Lumbar Radiculopathy
  • Small-fiber allodynia in Complex Regional Pain Syndrome (CRPS)
  • Underlying Central Nervous System impairment in difficult-to-diagnose patients
  • Early detection of diabetic neuropathy of small-caliber nerve fibers
  • Effectiveness of growth factors, aldosereductase
  • Inhibitors and other new therapies
  • Entrapment and toxic neuropathies
  • Testing programs to detect malingerers
  • Nerve root compression and inflammation